sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human...

Home / Categories / Healthcare
Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021
Endocrine Testing Market (Dehydroepiandrosterone Sulfate,...
Report Code
RO1/106/1023

Publish Date
18/Nov/2016

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Endocrine Testing Market, 2015 - 2021 (USD Million)

2.2. Global Endocrine Testing Market: Snapshot

Chapter 3. Endocrine Testing  Market Dynamics


3.1. Introduction

3.2. Market Drivers


3.2.1. Global Endocrine testing Market Drivers: Impact Analysis

3.2.2. Rising Diabetic and Obese Population

3.3. Market Restraints


3.3.1. Global Endocrine testing Market Restraints: Impact Analysis

3.3.2. High Cost of Technology

3.4. Opportunities


3.4.1. Innovative Products

3.5. Porters Five Forces Analysis


3.5.1. Bargaining Power Of Suppliers

3.5.2. Bargaining Power Of Buyers

3.5.3. Threat From New Entrants

3.5.4. Threat From New Substitutes

3.5.5. Degree Of Competition

3.6. Market Attractiveness Analysis


3.6.1. Market Attractiveness Analysis, By Test Segment

3.6.2. Market Attractiveness Analysis, By Technology Segment

3.6.3. Market Attractiveness Analysis, By End-User Segment

3.6.4. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global Endocrine Testing Market  Competitive Landscape


4.1. Company Market Share, 2015 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Regional Expansion

4.3. Type Portfolio

Chapter 5. Global Endocrine Testing Market  Test Analysis


5.1. Global Endocrine Testing Market: Test Segment Overview


5.1.1. Global Endocrine Testing Market Revenue Share, By Test, 2015 And 2021

5.2. Dehydroepiandrosterone Sulfate


5.2.1. Global Endocrine Testing Market for Dehydroepiandrosterone Sulfate, 2015  2021 (USD Million)

5.3. Progesterone


5.3.1. Global Endocrine Testing Market for Progesterone, 2015  2021 (USD Million)

5.4. Luteinizing Hormone


5.4.1. Global Endocrine Testing Market For Luteinizing Hormone, 2015  2021 (USD Million)

5.5. Estradiol


5.5.1. Global Endocrine Testing Market for Estradiol, 2015  2021 (USD Million)

5.6. Human Chorionic Gonadotropin


5.6.1. Global Endocrine Testing Market for Human Chorionic Gonadotropin, 2015  2021 (USD Million)

5.7. Follicle Stimulating


5.7.1. Global Endocrine Testing Market for Follicle Stimulating, 2015  2021 (USD Million)

5.8. Testosterone


5.8.1. Global Endocrine Testing Market for Testosterone, 2015  2021 (USD Million)

5.9. Thyroid Prolactin


5.9.1. Global Endocrine Testing Market for Thyroid Prolactin, 2015  2021 (USD Million)

5.10. Thyroid Stimulating Hormone


5.10.1. Global Endocrine Testing Market for Thyroid Stimulating Hormone, 2015  2021 (USD Million)

5.11. Cortisol


5.11.1. Global Endocrine Testing Market for Cortisol, 2015  2021 (USD Million)

5.12. Insulin


5.12.1. Global Endocrine Testing Market for Insulin, 2015  2021 (USD Million)

5.13. Others


5.13.1. Global Endocrine Testing Market for Other Test, 2015  2021 (USD Million)

Chapter 6. Global Endocrine Testing Market  Technology Segment Analysis


6.1. Global Endocrine testing Market: Technology Segment Overview


6.1.1. Global Endocrine testing Market Revenue Share, By Technology, 2015 And 2021

6.2. Monoclonal  Polyclonal Antibody Technologies


6.2.1. Global Endocrine Testing Market For Monoclonal  Polyclonal Antibody Technologies, 2015  2021 (USD Million)

6.3. Tandem Mass Spectrometry


6.3.1. Global Endocrine Testing Market For Tandem Mass Spectrometry, 2015  2021 (USD Million)

6.4. Immunoassay


6.4.1. Global Endocrine Testing Market for Immunoassay, 2015  2021 (USD Million)

6.5. Clinical Chemistry Technologies


6.5.1. Global Endocrine Testing Market for Clinical Chemistry Technologies, 2015  2021 (USD Million)

6.6. Other


6.6.1. Global Endocrine Testing Market for Other Technologies, 2015  2021 (USD Million)

Chapter 7. Global Endocrine Testing Market  End-User Segment Analysis


7.1. Global Endocrine testing Market: End-User Segment Overview


7.1.1. Global Endocrine testing Market Revenue Share, By End-User, 2015 And 2021

7.2. Commercial Laboratories


7.2.1. Global Endocrine Testing Market For Commercial Laboratories, 2015  2021 (USD Million)

7.3. Home-Based Tests


7.3.1. Global Endocrine Testing Market for Home-Based Tests 2015  2021 (USD Million)

7.4. Ambulatory Care Centers


7.4.1. Global Endocrine Testing Market for Ambulatory Care Centers 2015  2021 (USD Million)

7.5. Hospitals


7.5.1. Global Endocrine Testing Market for Hospitals 2015  2021 (USD Million)

7.6. Other


7.6.1. Global Endocrine Testing Market for other, 2015  2021 (USD Million)

Chapter 8. Global Endocrine Testing Market  Regional Segment Analysis


8.1. Global Endocrine Testing Market: Regional Overview


8.1.1. Global Endocrine Testing Market Revenue Share, By Region, 2015 And 2021

8.2. North America


8.2.1. North America Endocrine Testing Market Revenue, By Test, 2015  2021 , (Usd Million)

8.2.2. North America Endocrine Testing Market Revenue, By Technology, 2015  2021 , (USD Million)

8.2.3. North America Endocrine Testing Market Revenue, By End-User Type, 2015  2021 , (USD Million)

8.3. Europe


8.3.1. Europe Endocrine Testing Market Revenue, By Test, 2015  2021 (USD Million)

8.3.2. Europe Endocrine Testing Market Revenue, By Technology, 2015  2021 (USD Million)

8.3.3. Europe Endocrine Testing Market Revenue, By End-User Type, 2015  2021 (USD Million)

8.4. Asia Pacific


8.4.1. Asia Pacific Endocrine Testing Market Revenue, By Test, 2015  2021 (USD Million)

8.4.2. Asia Pacific Endocrine Testing Market Revenue, By Technology, 2015  2021 (USD Million)

8.4.3. Asia Pacific Endocrine Testing Market Revenue, By End-User Type, 2015  2021 (USD Million)

8.5. Latin America


8.5.1. Latin America Endocrine Testing Market Revenue, By Test, 2015  2021 (USD Million)

8.5.2. Latin America Endocrine Testing Market Revenue, By Technology, 2015  2021 (USD Million)

8.5.3. Latin America Endocrine Testing Market Revenue, By End-User Type, 2015  2021 (USD Million)

8.6. Middle East And Africa


8.6.1. Middle East And Africa Endocrine Testing Market Revenue, By Test, 2015  2021 (USD Million)

8.6.2. Middle East And Africa Endocrine Testing Market Revenue, By Technology, 2015  2021 (USD Million)

8.6.3. Middle East And Africa Endocrine Testing Market Revenue, By End-User Type, 2015  2021 (USD Million)

Chapter 9. Company Profile


9.1. Abbott Laboratories


9.1.1. Overview

9.1.2. Financials

9.1.3. Product Portfolio

9.1.4. Business Strategy

9.1.5. Recent Developments

9.2. AB Sciex Pte.Ltd.


9.2.1. Overview

9.2.2. Financials

9.2.3. Product Portfolio

9.2.4. Business Strategy

9.2.5. Recent Developments

9.3. Agilent Technologies


9.3.1. Overview

9.3.2. Financials

9.3.3. Product Portfolio

9.3.4. Business Strategy

9.3.5. Recent Developments

9.4. Biomedical Technologies.


9.4.1. Overview

9.4.2. Financials

9.4.3. Product Portfolio

9.4.4. Business Strategy

9.4.5. Recent Developments

9.5. bioMerieux SA


9.5.1. Overview

9.5.2. Financials

9.5.3. Product Portfolio

9.5.4. Business Strategy

9.5.5. Recent Developments

9.6. Bio-Rad Laboratories.


9.6.1. Overview

9.6.2. Financials

9.6.3. Product Portfolio

9.6.4. Business Strategy

9.6.5. Recent Developments

9.7. DiaSorin S.p.A.


9.7.1. Overview

9.7.2. Financials

9.7.3. Product Portfolio

9.7.4. Business Strategy

9.7.5. Recent Developments

9.8. Hoffmann-La Roche Ltd.


9.8.1. Overview

9.8.2. Financials

9.8.3. Product Portfolio

9.8.4. Business Strategy

9.8.5. Recent Developments

9.9. Quest Technology


9.9.1. Overview

9.9.2. Financials

9.9.3. Product Portfolio

9.9.4. Business Strategy

9.9.5. Recent Developments

9.10. Thermo Fisher Scientific, Inc.


9.10.1. Overview

9.10.2. Financials

9.10.3. Product Portfolio

9.10.4. Business Strategy

9.10.5. Recent Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com